PDGFRB and hearing loss disorder: A study by Park et al. found that the delivery of dexamethasone-loaded nanoparticles conjugated with a PDGFRβ antibody into the cochlea of mice with noise-induced hearing loss led to a significant increase in pericyte coverage and a significant improvement in hearing function, compared to non-targeted nanoparticles or free dexamethasone [349].